Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/462c8f54-31b5-48ab-9dcd-36d650637918/

MOBI

Mobia Medical, Inc. Common Stock
Chart
10.85 USD
Latest Week 2026-07-24
HealthcareMedical DevicesSMALL
Snapshot 2026-07-26 · 0.4w · Fresh
0.5
OS Score
49.0%
Value
47.0%
Quality
49.0%
Momentum
5/9
F-Score
0.480
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
49.0%ile
P/S
11.3×
FCF Yield
-0.128
SH Yield
-0.179
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
52.00000000
/100 — 1=cheapest
VC2 (Trending Value)
52.00000000
/100
VC3 (Buyback)
52.00000000
/100
Negative FCF yield (-12.8%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
47.0%ile
ROE
0.277
ROA
-0.632
Net Margin
-1.451
Op Margin
-1.447
GPA
0.351
D/E
-1.44
Current
6.06
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
1.048
Accruals
-0.011
lower=better
5yr Consist
No
ROE of 28% is exceptional. Conservative balance sheet with D/E of -1.44.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
49.0%ile
Vol 252d
55.8%
Vol 60d
55.8%
↓ Contracting
Max DD 12M
-25.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.5
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
25.5%
Sector Quality %ile
22.6%
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
PBYI Puma Biotechnology Inc 97.0% 79.0% 97.0% 96.0%
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
8.5% avg (3 factors)
Quality
C
51.7% avg (8 factors)
Risk
F
23.7% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.500—0—
Value %ile0.490—0—
Quality %ile0.470—0—
Momentum %ile0.490—0—
F-Score5.000—0—
Confidence0.581—0—
Volatility0.558—3—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
11.26
FCF Yield
-12.8%
Sales Yield (1/P·S)
0.0904
Shareholder Yield
Div + net buyback / mktcap
-17.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
27.7%
Return on Assets
-63.2%
Net Margin
-145.1%
Operating Margin
-144.7%
Gross Profit / Assets
Novy-Marx GPA
35.1%
Debt / Equity
-1.44
Current Ratio
6.06
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.011
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
104.8%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
-17.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
52
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
52
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
52
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity